NONALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR COMPLICATIONS -WHAT IS THE RELATIONSHIP?
https://doi.org/10.38109/2225-1685-2013-1-69-75
Abstract
Nonalcoholic fatty liver disease (NAFLD) is one of the most common diseases in hepatology, which leads to a deterioration in the quality of life, disability and death. NAFLD occurs in all age groups, but the most vulnerable are women aged 40-60 years with signs of metabolic syndrome (MS). After being diagnosed NAFLD patients should be screened for the presence of their associated diseases, such as metabolic syndrome and cardiovascular disease. During the past years the role and function of adipose tissue was restudied, what leaded to the active scientific study of the molecular mechanisms of biosynthesis of fat producing hormones and their role in the development of obesity, insulin resistance and associated cardiovascular disease. All medical researches carried out in this area are promising and relevant, but the data are rather contradictory and require further research to produce new true facts that could form the basis for new diagnostic and therapeutic strategies for metabolic abnormalities in patients with cardiovascular disease.
About the Authors
V. A. Azizov
Azerbaijan Medical University
Russian Federation
Russian Federation
A. K. Alekperova
Azerbaijan Medical University
Russian Federation
Russian Federation
A. S. Ragimova
Azerbaijan Medical University
Russian Federation
Russian Federation
V. S. Mammadova
Azerbaijan Medical University
Russian Federation
Russian Federation
L. G. Efendiyeva
Azerbaijan Medical University
Russian Federation
Russian Federation
T. A. Sadigova
Azerbaijan Medical University
Russian Federation
Russian Federation
References
1. С. Н. Мехтиев, В. Б. Гриневич, Ю. А. Кравчук, А.В. Бращенкова. "Неалкогольная жировая болезнь печени: клиника, диагностика и лечение", Гастроэнтерология, 2008 г., № 2
2. Чазова И.Е., Мычка В.Б. Метаболический синдром // Consilium medicum. - 2004.
3. WHO. Prevention and management of the global epidemic of obesity: Report of the WHO consultation on obesity. - Geneva, 1997.
4. Бабак О.Я. Причины и метаболические последствия неалкогольной жировой болезни печени // Сучасна гастроентерологія. - 2010. - № 4 (54). - С. 8-16.
5. Kistler K.D., Molleston J., Unalp A., Abrams S.H., Behling C., Schwimmer J.B. Symptoms and Quality of Life in Obese Children and Adolescents with Non-alcoholic Fatty Liver Disease Posted: 02/01/2010 // Alimentary Pharmacology & Therapeutics. - 2010. - 31 (3). - 396-406.
6. Schwimmer J.B., Deutsch R., Kahen T., Lavine J.E., Stanley C., Behling C. Prevalence of fatty liver in children and adolescents // Pediatrics. - 2006. -118 (4). - 1388-93.
7. Подымова С.Д. Жировой гепатоз. Неалкогольный стеатогепатит (эволюция представлений о клинико-морфологических особенностях, прогнозе, лечении) / Тер. арх. - 2006. - № 4. - С. 32-38.
8. Greenland P., Knoll M.D., Stamler J. et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events // JAMA. - 2003. - V. 290(7). - Р. 891-7.
9. Kaplan N.M. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia and hypertension // Arch. Intern. Med. - 1989. -Vol. 149. - P. 1514-1520.
10. Muse E.D. Role of resistin in diet induced hepatic insulin resistance / E.D. Muse, S. Obici, S. Bhanot et al. // J. Clin. Invest. - 2004. - Vol. 114. - P. 232-239.
11. Бабак О.Я. Роль адипокинов в развитии фиброза печени при неалкогольной жировой болезни / О.Я. Бабак, Е.В. Колесникова // Сучасна гастроентерологія. - 2009. - № 5(49). - С. 5-11.
12. Bokarewa M. Resistin, an adipokine with potent proinflammatory properties / M. Bokarewa, I. Nagaev, L. Dahlberg et al. // J. Immunol. - 2005. -Vol. 174. - P. 5789-5795.
13. Lehrke M. An inflammatory cascade leading to hyperresistinemia in humans / M. Lehrke, M.P Reilly, S.C. Millington et al. // PLoS Med. - 2004. -Vol. 1. - P. 45.
14. Burnett M.S., Devaney J.M., Adenika R.J. CrossSectional Associations of Resistin, Coronary Heart Disease, and Insulin Resistance // J. Clin. Endocrinol. Metab. - 2006. - Vol. 91(1). - P 64-68.
15. Scherer P.E., Williams S., Fogliano M. et al. A novel serum protein similar to C1q, produced exclusively in adipocytes // J. Biol. Chem. - 1995. - Vol. 270. - P. 26746-26749.
16. Hu E., Liang P., Spiegelman B.M. AdipoQ is a novel adiposespecific gene dysregulated in obesity // J. Biol. Chem. - 1996. - Vol. 271. - P. 10697-10703.
17. Matsuzawa Y., Funahashi T., Kihara S., Shimomura I. Adiponectin and Metabolic Syndrome // Arterioscler. Thromb. Vase. Biol. - 2004. - Vol. 24. -P. 29-33.
18. Mallamaci F., Zoccali C., Cuzzola F. et al. Adiponectin and essential hypertension // J. Nephrol. - 2002. -Vol. 15. - P. 507-511.
19. Kumada M., Kihara S., Sumitsuji S. et al. Association of hypoadiponectinemia with coronary artery disease in men // Arterioscler. Thromb. Vase. Biol. - 2003. - Vol. 23. - P. 85-89.
20. Pischon T., Girman C.J., Hotamisligil G.S. et al. Plasma Adiponectin Levels and Risk of Myocardial Infarction in Men // JAMA. - 2004. - Vol. 291(14). -P. 1730-1737.
21. Matsuda M., Shimomura I., Sata M. et al. Role of adiponectin in preventing vascular stenosis: The missing link of adipo-vascular axis // J. Biol. Chem. - 2002. - Vol. 277. - P. 37487.
22. Okamoto Y., Arita Y., Nishida M. et al. An adi-pocyte-derived plasma protein, adiponectin, adheres to injures vascular walls // Horm. Metab. Res. - 2000. - Vol. 32. - P. 47.
23. Kojima M., Hosoda H., Date Y. et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach // Nature. - 1999. - Vol. 402. - P. 656-60.
24. Cowley M.A. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis // Neuron. - 2003. - Vol. 37. - P. 649661.
25. Mori K. Kidney produces a novel acylated peptide, ghrelin // FEBS Lett. - 2003. - Vol. 486. - P. 213-6.
26. Lee H.-M., Wang G., Englander E.W. et al. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine and dietary manipulations // Endocrinology. - 2002. - Vol. 143. - P 185-190.
27. Poykko S.M., Kellokoski E., Horkko S. et al. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes // Diabetes. - 2003. - Vol. 52. - P 2546-2553.
28. Mertens I., Van Gaal L.F. Obesity, haemostasis and the fibrinolytic system // Obes. Rev. - 2002. - Vol. 3(2). - P. 85-101.
29. Margaglione M., Cappucci G., d'Addedda M. et al. PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants // Arterioscler. Thromb. Vasc. Biol. - 1998. - Vol. 18(4) - P 562.
30. Wiman B., Andersson T. et al. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study // Arterioscler. Thromb. Vasc. Biol. - 2000. - Vol. 20(8). - P 2019-23.
31. Aizawa-Abe M. Pathophysiological role of leptin in obesity-related hypertension // J. Clin. Invest. -2000. - Vol. 105. - P. 1243-1252.
32. Van Harmelen V., Ariapart P., Hoffstedt J. et al. Increased adipose angiotensinogen gene expression in human obesity // Obes. Res. - 2000. - Vol. 8. - P 337-341.
33. Wood S.C., Seeley R.J. Adiposity signals and the control of energy homeostasis // Nutrition. -2000. - № 13. - P. 894-902.
34. Seeley R.J., Schwartz M.W. Neuroendocrine regulation of food intake // Acta Pediatr. Suppl. -1999. - Vol. 88. - P 58-61.
35. Woods S.C., Chavez M., Park C.R. et al. The evaluation of insulin as a metabolic signal controlling behavior via the brain // Neurosci Brobehav Rev. - 1996. - Vol. 20. - P. 139-144.
Review
For citations:
Azizov V.A., Alekperova A.K., Ragimova A.S., Mammadova V.S., Efendiyeva L.G., Sadigova T.A. NONALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR COMPLICATIONS -WHAT IS THE RELATIONSHIP? Eurasian heart journal. 2013;(1):69-75. (In Russ.) https://doi.org/10.38109/2225-1685-2013-1-69-75
Views:
337
Email this article 
